4 ms·
There's a missing externality (opportunity cost) in the FDA's vaccine calculus: if the vaccine does have an unexpected and negative side effect it could affect
by gumby 6y ago
There's a missing externality (opportunity cost) in the FDA's vaccine calculus: if the vaccine does have an unexpected and negative side effect it could affect willingness to inoculate for other and even more lethal illnesses.
It's not like the FDA doesn't understand that people suffer every day a new medication isn't approved. In fact they've been experimenting, -- yes slowly -- with adaptive trial designs that are more flexible than the stereotype of rigid Phase I/II/III